| 000 | 01846 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516121346.0 | ||
| 264 | 0 | _c20131017 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1578-1267 | ||
| 024 | 7 |
_a10.1016/j.aller.2012.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarogna, M | |
| 245 | 0 | 0 |
_aThe contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial. _h[electronic resource] |
| 260 |
_bAllergologia et immunopathologia _c |
||
| 300 |
_a216-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAcetates _xtherapeutic use |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAllergens _xadverse effects |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthma _xetiology |
| 650 | 0 | 4 |
_aBetula _xadverse effects |
| 650 | 0 | 4 |
_aBudesonide _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 |
_aDesensitization, Immunologic _xmethods |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPollen _xadverse effects |
| 650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSulfides |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBraidi, C | |
| 700 | 1 | _aBruno, M E | |
| 700 | 1 | _aColombo, C | |
| 700 | 1 | _aColombo, F | |
| 700 | 1 | _aMassolo, A | |
| 700 | 1 | _aPalumbo, L | |
| 700 | 1 | _aCompalati, E | |
| 773 | 0 |
_tAllergologia et immunopathologia _gvol. 41 _gno. 4 _gp. 216-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.aller.2012.07.004 _zAvailable from publisher's website |
| 999 |
_c22254359 _d22254359 |
||